Stop using now Drug recall · FDA · Published October 21, 2026

Novadoz Recalls Atorvastatin 40mg Due to Foreign Tablets

Novadoz Pharmaceuticals recalls 13,296 bottles of Atorvastatin Calcium Tablets 40mg due to the presence of foreign tablets or capsules.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0113-2027Drug Novadoz Pharmaceuticals ›

Stop using this now

Presence of Foreign Tablets/Capsules

✎ GovInfoNow plain-language explainer

Novadoz Pharmaceuticals LLC is recalling specific lots of Atorvastatin Calcium Tablets, USP, 40mg because they may contain foreign tablets or capsules. The affected product consists of 13,296 bottles containing 1,000 tablets each. This recall was issued on October 21, 2026. Read more at govinfonow.com/recall/2084711-msn-laboratories-private-limited-formulations-division-unit-ii-recalls-atorvastatin.

Source Summary by GovInfoNow · govinfonow.com/recall/2084711-msn-laboratories-private-limited-formulations-division-unit-ii-recalls-atorvastatin · Published November 10, 2026 · Updated November 11, 2026 · FDA enforcement record: FDA #D-0113-2027

Cite this page

“Novadoz Recalls Atorvastatin 40mg Due to Foreign Tablets.” GovInfoNow, updated November 11, 2026. https://govinfonow.com/recall/2084711-msn-laboratories-private-limited-formulations-division-unit-ii-recalls-atorvastatin. Based on FDA recall #D-0113-2027 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0113-2027%22&limit=1).

The FDA announced on October 21, 2026, that Novadoz Pharmaceuticals is recalling Atorvastatin Calcium Tablets, USP, 40mg due to the presence of foreign tablets or capsules. The recall involves 13,296 bottles distributed nationwide.

How to tell if you have it

Brand: Novadoz Pharmaceuticals
Product: Atorvastatin Calcium Tablets, USP, 40mg
NDC: 72205-024-99
Lot codes: DRF09618A (Exp 08-31-2029), DRG02110A (Exp 01-31-2030)
Quantity: 1,000 tablets per bottle
Distribution: Nationwide in the USA

The hazard

The recall is due to the presence of foreign tablets or capsules within the Atorvastatin Calcium Tablets bottles. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show other recent recalls of similar products include Teva Recalls Metoclopramide Tablets Due to Foreign Contaminants (2026-09-29) and American Health Packaging Recalls Metoclopramide Tablets Due to Foreign Drug Presence (2026-10-06). Bionpharma Divalproex Tablets Recall: Foreign Tablets Risk was reported on 2026-06-26.

How to tell if you have this one

Check your bottle for NDC 72205-024-99 and verify if the lot number is DRF09618A (Expiration Date 08-31-2029) or DRG02110A (Expiration Date 01-31-2030). The bottles contain 1,000 tablets and were distributed nationwide in the USA.

Brand
Novadoz Pharmaceuticals
Category
Drug

Based on the official FDA remedy

What to do — step by step

Stop taking the medication
Do not consume any tablets from the affected lots due to the risk of foreign contamination.
Contact your pharmacist or doctor
Inform your healthcare provider about the recall and discuss alternative treatment options.

Where it went and when

Where it was distributed

Distributed nationwide.

FDA distribution: “Nationwide in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 14 days after the firm started it.

Oct 21, 2026Firm started the recall
Oct 29, 2026FDA classified it Class II
Nov 4, 2026Published in FDA’s Enforcement Report
Nov 10, 2026Added to GovInfoNow

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/2084711-msn-laboratories-private-limited-formulations-division-unit-ii-recalls-atorvastatin">Novadoz Recalls Atorvastatin 40mg Due to Foreign Tablets (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0113-2027 (October 21, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0113-2027 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on November 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.